Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. RTO
RTO logo

RTO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Rentokil Initial PLC (RTO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
34.060
1 Day change
0.56%
52 Week Range
34.660
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Rentokil Initial PLC is not a strong buy at this moment for a beginner, long-term investor with $50,000-$100,000 to invest. While there are positive indicators such as hedge fund buying and recent analyst upgrades, the lack of a clear AI Stock Pick or SwingMax signal, combined with the technical indicators showing a neutral RSI and limited short-term upside potential, suggests that this is not an optimal entry point. Additionally, the pre-market price decline and absence of recent news or financial data further reduce the attractiveness of the stock at this time.

Technical Analysis

The technical indicators show a mixed picture. The MACD is positive and contracting, indicating some bullish momentum, while the RSI is neutral at 56.788. The moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading near its pivot point of 33.296, with resistance at 34.433 and support at 32.16. Short-term candlestick analysis suggests a 50% chance of a -0.18% decline in the next day and a -6.79% decline over the next month.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
8

Positive Catalysts

  • Hedge funds are significantly increasing their positions, with a 181.06% increase in buying over the last quarter.

  • Recent analyst upgrades and increased price targets, including UBS turning positive on the stock for the first time since

  • Bullish moving averages indicating some upward momentum.

Neutral/Negative Catalysts

  • Pre-market price decline of -0.30%, indicating potential weakness.

  • Absence of recent news or financial performance data to support a strong buy decision.

  • Neutral insider trading trends and no recent congress trading activity.

  • Short-term stock trend analysis suggests potential declines in the coming days and weeks.

Financial Performance

No financial data available for analysis due to an error in the provided data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is generally positive, with multiple upgrades and increased price targets. Citi, UBS, and Morgan Stanley have all raised their price targets, and UBS has turned positive on the stock, citing balanced costs and organic growth recovery. However, Deutsche Bank downgraded the stock to Hold, citing underperformance in the pest control category compared to peers.

Wall Street analysts forecast RTO stock price to fall
1 Analyst Rating
Wall Street analysts forecast RTO stock price to fall
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 33.870
sliders
Low
6.72
Averages
6.72
High
6.72
Current: 33.870
sliders
Low
6.72
Averages
6.72
High
6.72
Citi
Marc Van'T Sant
Buy
maintain
$550 -> $575
AI Analysis
2026-03-16
Reason
Citi
Marc Van'T Sant
Price Target
$550 -> $575
AI Analysis
2026-03-16
maintain
Buy
Reason
Citi analyst Marc Van'T Sant raised the firm's price target on Rentokil Initial to 575 GBp from 550 GBp and keeps a Buy rating on the shares.
UBS
Nicole Manion
Neutral -> Buy
upgrade
2026-03-12
Reason
UBS
Nicole Manion
Price Target
2026-03-12
upgrade
Neutral -> Buy
Reason
UBS analyst Nicole Manion upgraded Rentokil Initial to Buy from Neutral with a price target of 540 GBp, up from 430 GBp. The firm says that for the first time since 2020, it turns positive on Rentokil. The company's organic volumes look on track to return to growth and its costs look balanced, the analyst tells investors in a research note. UBS believes a "valuable compounder could be re-emerging."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for RTO
Unlock Now

People Also Watch